TL;DR
This study compares laparoscopic pancreaticoduodenectomy (LPD) with open pancreaticoduodenectomy (OPD) for pancreatic ductal adenocarcinoma (PDAC), finding LPD to be technically feasible with similar long-term survival and fewer complications, particularly delayed gastric emptying. This suggests LPD is a viable alternative for PDAC patients, provided surgeons have adequate training and experience.
What Problem Does This Paper Address?
Pancreatic ductal adenocarcinoma (PDAC) is a deadly cancer, and surgical resection remains the primary curative option. While laparoscopic surgery has become more common for other pancreatic procedures, its adoption for PDAC, specifically pancreaticoduodenectomy (the Whipple procedure), has been slower. This is due to the procedure's complexity and lingering questions about its long-term efficacy and safety compared to traditional open surgery. Previous studies have often been limited by small sample sizes, mixed patient populations, or a lack of robust statistical methods to control for confounding factors. This paper aims to address this gap by rigorously comparing the short- and long-term outcomes of LPD versus OPD for PDAC using a propensity score matching analysis.
Methods
The researchers conducted a retrospective study analyzing data from patients who underwent either LPD or OPD for pathologically confirmed PDAC between January 2013 and September 2017. To account for potential biases and differences in patient characteristics between the two groups, they employed a propensity score matching (PSM) technique. This involved using logistic regression to calculate a propensity score for each patient and then matching patients in a 2:1 ratio (OPD to LPD) based on these scores. This ensured that the matched groups were as similar as possible in terms of baseline characteristics, allowing for a more direct comparison of outcomes.
Key outcomes assessed included:
- Operative characteristics: operative time, estimated blood loss, blood transfusion, and lymph node retrieval.
- Postoperative outcomes: complications such as postoperative pancreatic fistula (POPF), delayed gastric emptying (DGE), postpancreatectomy hemorrhage (PPH), bile leakage (BL), intra-abdominal infection, wound infection, and overall complication rates (categorized by Clavien-Dindo grading).
- Survival: median overall survival (OS) was the primary endpoint.
Statistical analyses included t-tests, Mann-Whitney U tests, Chi-square tests, Fisher's exact tests, and Kaplan-Meier survival analysis with log-rank tests.
Datasets
The study utilized data from two high-volume pancreatic surgical centers: Zhongshan Hospital, Fudan University (Shanghai, China) for OPD, and Zhejiang Provincial People's Hospital (Hangzhou, Zhejiang, China) for LPD. The dataset comprised 329 patients initially, with 309 ultimately included after exclusions and matching. No new datasets or benchmarks were introduced.
Key Insights and Ideas
- LPD is technically feasible for PDAC: Despite its complexity, the study demonstrates that LPD can be successfully performed for PDAC.
- Reduced Delayed Gastric Emptying (DGE) with LPD: A significant finding is the substantially lower incidence of DGE, particularly the more severe grades (B/C), in the LPD group compared to the OPD group. This is a common and troublesome complication after pancreaticoduodenectomy.
- Overall complication reduction with LPD: The LPD group experienced a lower overall complication rate, largely driven by a reduction in minor complications (Clavien I-II).
- Similar Oncological Outcomes: Crucially, after propensity score matching, the median overall survival was comparable between the LPD and OPD groups, suggesting that LPD does not compromise oncological efficacy.
- The Learning Curve Matters: The discussion highlights the importance of the learning curve for LPD. Early-phase LPD cases in this study and in other literature showed higher complication rates and longer operative times, underscoring the need for experienced surgeons and adequate training.
Key Results
- After 2:1 propensity score matching, 93 patients were in the OPD group and 55 in the LPD group.
- LPD was associated with significantly longer operative times (330.0 vs. 260.0 min, P<0.001) and a lower amount of estimated blood loss (150.0 vs. 200.0 mL, P=0.001) in the matched cohort.
- Delayed gastric emptying (DGE), especially grade B/C, occurred significantly less frequently in the LPD group (1.8% vs. 36.6%, P<0.001).
- Overall complication rates were significantly lower in the LPD group (49.1% vs. 71.0%, P=0.008).
- Rates of major complications (Clavien III-V) were similar between groups (10.9% vs. 14.0%, P=0.590).
- Median overall survival was comparable between the LPD and OPD groups (20.0 vs. 18.7 months, P=0.293).
- The LPD group had a higher rate of reoperation in the original cohort (6.3% vs. 1.3%), which was attributed to early-phase LPD cases and potentially learning curve effects.
Limitations and Future Work
The authors acknowledge several limitations:
- Retrospective Design: The study is retrospective, which inherently carries limitations in data collection and potential biases.
- Two Independent Institutions: The LPD and OPD cases originated from different institutions, which could introduce variations in surgical techniques, postoperative management, and data recording. While PSM helped, it cannot entirely eliminate institutional bias.
- Short Follow-up Period: The median follow-up of 11.2 months limits the analysis of long-term oncological outcomes, such as disease-free survival.
- Inability to Evaluate Disease-Free Survival: This was not assessed in the current retrospective analysis.
Future work should focus on establishing standardized training programs and efficient learning curve management for LPD in pancreaticoduodenectomy. Further prospective, multi-center studies with longer follow-up periods are needed to confirm these findings and explore disease-free survival.
Summary updated